{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T09:14:48Z","timestamp":1764494088392,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702161","81802508","81903398"],"award-info":[{"award-number":["81702161","81802508","81903398"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010229","name":"Natural Science Foundation of Tianjin Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["17JCQNJC11000"],"award-info":[{"award-number":["17JCQNJC11000"]}],"id":[{"id":"10.13039\/501100010229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The objectives were to investigate the disparity in the prevalence of bone metastases (BM) between the sexes and to assess the effect of female sex on the development and prognosis of BM.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Cases of invasive non-sex-specific cancers diagnosed between 2010 and 2015 in the Surveillance, Epidemiology, and End Results (SEER) program were used. The prevalence of BM was calculated by combining the prevalence of BM among different cancers. Multivariable logistic regression and proportion hazard regression were conducted to investigate the effect of female sex, and the results were pooled by meta-analysis.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The pooled prevalence of BM among male and female patients was 2.3% (95% CI: 1.6\u20133.2%) and 1.8% (95% CI: 1.2\u20132.6%), respectively. The pooled prevalence of BM dramatically decreased for patients aged 11\u201340\u2009years old, plateaued for patients aged 41\u201390\u2009years old and increased for patients aged &gt;\u200990\u2009years old in both male and female patients. Meta-analysis suggested that female sex had a protective effect on the development of BM (pooled OR\u2009=\u20090.80; 95% CI: 0.75\u20130.84; <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.001) and a favourable prognosis for respiratory system cancers (pooled HR\u2009=\u20090.81; 95% CI: 0.71\u20130.92; <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.001). However, no significant associations existed for other cancers. Male non-sex-specific cancer patients and those with male-leaning genetic variations or hormonal status have a greater likelihood of developing BM than female patients.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Female sex was associated with fewer BM in various non-sex-specific cancers, and the effect was constant with changes in age. Female sex showed a protective effect exclusively on the prognosis of respiratory system cancers.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-019-6168-1","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T18:26:01Z","timestamp":1572027961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Female sex is associated with a lower risk of bone metastases and favourable prognosis in non-sex-specific cancers"],"prefix":"10.1186","volume":"19","author":[{"given":"Wenjuan","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Peltzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisha","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guijun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir P.","family":"Chekhonin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"issue":"2","key":"6168_CR1","first-page":"121","volume":"10","author":"T Ibrahim","year":"2013","unstructured":"Ibrahim T, Mercatali L, Amadori D. Bone and cancer: the osteoncology. Clin Cases Miner Bone Metab. 2013;10(2):121\u20133.","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"9","key":"6168_CR2","doi-asserted-by":"publisher","first-page":"e16022","DOI":"10.1136\/bmjopen-2017-016022","volume":"7","author":"E Svensson","year":"2017","unstructured":"Svensson E, Christiansen CF, Ulrichsen SP, Rorth MR, Sorensen HT. Survival after bone metastasis by primary cancer type: a Danish population-based cohort study. BMJ Open. 2017;7(9):e16022.","journal-title":"BMJ Open"},{"issue":"1","key":"6168_CR3","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1186\/s40064-016-2741-0","volume":"5","author":"A Idota","year":"2016","unstructured":"Idota A, Sawaki M, Yoshimura A, Hattori M, Inaba Y, Oze I, et al. Bone scan index predicts skeletal-related events in patients with metastatic breast cancer. Springerplus. 2016;5(1):1095.","journal-title":"Springerplus."},{"issue":"6","key":"6168_CR4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nrclinonc.2011.67","volume":"8","author":"J Sturge","year":"2011","unstructured":"Sturge J, Caley MP, Waxman J. Bone metastasis in prostate cancer: emerging therapeutic strategies. Nat Rev Clin Oncol. 2011;8(6):357\u201368.","journal-title":"Nat Rev Clin Oncol"},{"key":"6168_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.canep.2019.05.013","volume":"61","author":"YH Baek","year":"2019","unstructured":"Baek YH, Jeon HL, Oh IS, Yang H, Park J, Shin JY. Incidence of skeletal-related events in patients with breast or prostate cancer-induced bone metastasis or multiple myeloma: A 12-year longitudinal nationwide healthcare database study. Cancer Epidemiol. 2019;61:104\u201310.","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"6168_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000489218","volume":"95","author":"T Owari","year":"2018","unstructured":"Owari T, Miyake M, Nakai Y, Morizawa Y, Itami Y, Hori S, et al. Clinical features and risk factors of skeletal-related events in genitourinary Cancer patients with bone metastasis: a retrospective analysis of prostate Cancer, renal cell carcinoma, and Urothelial carcinoma. Oncology. 2018;95(3):170\u20138.","journal-title":"Oncology."},{"key":"6168_CR7","doi-asserted-by":"publisher","unstructured":"Manders DB, Sims TT, Albuquerque KV, Carlson MJ, Richardson DL, Kehoe SM, et al. Emphasis on Systemic Therapy in Women With Pelvic Bone Metastasis at Time of Diagnosis of Cervical Cancer. Am J Clin Oncol. 2018. \n                    https:\/\/doi.org\/10.1097\/COC.0000000000000439\n                    \n                  .","DOI":"10.1097\/COC.0000000000000439"},{"key":"6168_CR8","doi-asserted-by":"publisher","unstructured":"Tablazon IL, Howard LE, De Hoedt AM, Aronson WJ, Kane CJ, Amling CL, et al. Predictors of skeletal-related events and mortality in men with metastatic, castration-resistant prostate cancer: results from the shared equal access regional Cancer hospital (SEARCH) database. Cancer Am Cancer Soc. 2019. \n                    https:\/\/doi.org\/10.1002\/cncr.32414\n                    \n                  .","DOI":"10.1002\/cncr.32414"},{"issue":"6","key":"6168_CR9","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/iju.13939","volume":"26","author":"T Owari","year":"2019","unstructured":"Owari T, Miyake M, Nakai Y, Hori S, Tomizawa M, Ichikawa K, et al. Clinical benefit of early treatment with bone-modifying agents for preventing skeletal-related events in patients with genitourinary cancer with bone metastasis: a multi-institutional retrospective study. Int J Urol. 2019;26(6):630\u20137.","journal-title":"Int J Urol"},{"issue":"51","key":"6168_CR10","doi-asserted-by":"publisher","first-page":"e9327","DOI":"10.1097\/MD.0000000000009327","volume":"96","author":"P Kong","year":"2017","unstructured":"Kong P, Yan J, Liu D, Ji Y, Wang Y, Zhuang J, et al. Skeletal-related events and overall survival of patients with bone metastasis from nonsmall cell lung cancer - a retrospective analysis. Medicine (Baltimore). 2017;96(51):e9327.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"6168_CR11","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s10147-016-1075-9","volume":"22","author":"Y Tsuda","year":"2017","unstructured":"Tsuda Y, Nakagawa T, Shinoda Y, Kanatani A, Kawai T, Taguchi S, et al. Skeletal-related events and prognosis in urothelial cancer patients with bone metastasis. Int J Clin Oncol. 2017;22(3):548\u201353.","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"6168_CR12","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s00520-015-2908-1","volume":"24","author":"R von Moos","year":"2016","unstructured":"von Moos R, Body JJ, Egerdie B, Stopeck A, Brown J, Fallowfield L, et al. Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases. Support Care Cancer. 2016;24(3):1327\u201337.","journal-title":"Support Care Cancer"},{"issue":"2","key":"6168_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.lungcan.2015.04.007","volume":"89","author":"M Kuchuk","year":"2015","unstructured":"Kuchuk M, Kuchuk I, Sabri E, Hutton B, Clemons M, Wheatley-Price P. The incidence and clinical impact of bone metastases in non-small cell lung cancer. Lung Cancer. 2015;89(2):197\u2013202.","journal-title":"Lung Cancer"},{"issue":"1","key":"6168_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4103\/0973-1482.110385","volume":"9","author":"V Bhandari","year":"2013","unstructured":"Bhandari V, Jain RK. A retrospective study of incidence of bone metastasis in head and neck cancer. J Cancer Res Ther. 2013;9(1):90\u20133.","journal-title":"J Cancer Res Ther"},{"issue":"7","key":"6168_CR15","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s11547-007-0205-x","volume":"112","author":"CC Quattrocchi","year":"2007","unstructured":"Quattrocchi CC, Piciucchi S, Sammarra M, Santini D, Vincenzi B, Tonini G, et al. Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions. Radiol Med. 2007;112(7):1049\u201359.","journal-title":"Radiol Med"},{"issue":"3","key":"6168_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s10549-016-3782-3","volume":"156","author":"A Liede","year":"2016","unstructured":"Liede A, Jerzak KJ, Hernandez RK, Wade SW, Sun P, Narod SA. The incidence of bone metastasis after early-stage breast cancer in Canada. Breast Cancer Res Treat. 2016;156(3):587\u201395.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"6168_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.lungcan.2014.07.020","volume":"86","author":"M Riihimaki","year":"2014","unstructured":"Riihimaki M, Hemminki A, Fallah M, Thomsen H, Sundquist K, Sundquist J, et al. Metastatic sites and survival in lung cancer. Lung Cancer. 2014;86(1):78\u201384.","journal-title":"Lung Cancer"},{"issue":"9","key":"6168_CR18","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.21037\/jtd.2017.08.72","volume":"9","author":"D Ai","year":"2017","unstructured":"Ai D, Zhu H, Ren W, Chen Y, Liu Q, Deng J, et al. Patterns of distant organ metastases in esophageal cancer: a population-based study. J Thorac Dis. 2017;9(9):3023\u201330.","journal-title":"J Thorac Dis"},{"issue":"2","key":"6168_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/BF02774186","volume":"24","author":"T Fukusato","year":"1989","unstructured":"Fukusato T, Aoyama H, Mori W. Age and sex differences in bone metastasis of hepatocellular carcinoma in Japanese autopsy cases. Gastroenterol Jpn. 1989;24(2):127\u201334.","journal-title":"Gastroenterol Jpn"},{"issue":"9","key":"6168_CR20","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/00042737-200109000-00015","volume":"13","author":"M Fukutomi","year":"2001","unstructured":"Fukutomi M, Yokota M, Chuman H, Harada H, Zaitsu Y, Funakoshi A, et al. Increased incidence of bone metastases in hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2001;13(9):1083\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"36","key":"6168_CR21","doi-asserted-by":"publisher","first-page":"38658","DOI":"10.18632\/oncotarget.6130","volume":"6","author":"M Qiu","year":"2015","unstructured":"Qiu M, Hu J, Yang D, Cosgrove DP, Xu R. Pattern of distant metastases in colorectal cancer: a SEER based study. Oncotarget. 2015;6(36):38658\u201366.","journal-title":"Oncotarget."},{"issue":"3","key":"6168_CR22","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s11999-007-0051-0","volume":"466","author":"H Sugiura","year":"2008","unstructured":"Sugiura H, Yamada K, Sugiura T, Hida T, Mitsudomi T. Predictors of survival in patients with bone metastasis of lung cancer. Clin Orthop Relat Res. 2008;466(3):729\u201336.","journal-title":"Clin Orthop Relat Res"},{"issue":"50","key":"6168_CR23","doi-asserted-by":"publisher","first-page":"82648","DOI":"10.18632\/oncotarget.12244","volume":"7","author":"R Berardi","year":"2016","unstructured":"Berardi R, Morgese F, Santinelli A, Onofri A, Biscotti T, Brunelli A, et al. Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex. Oncotarget. 2016;7(50):82648\u201357.","journal-title":"Oncotarget."},{"issue":"5","key":"6168_CR24","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.bone.2012.08.111","volume":"51","author":"KM Wiren","year":"2012","unstructured":"Wiren KM, Zhang XW, Olson DA, Turner RT, Iwaniec UT. Androgen prevents hypogonadal bone loss via inhibition of resorption mediated by mature osteoblasts\/osteocytes. Bone. 2012;51(5):835\u201346.","journal-title":"Bone."},{"issue":"12","key":"6168_CR25","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1002\/jbmr.1713","volume":"27","author":"M Sinnesael","year":"2012","unstructured":"Sinnesael M, Claessens F, Laurent M, Dubois V, Boonen S, Deboel L, et al. Androgen receptor (AR) in osteocytes is important for the maintenance of male skeletal integrity: evidence from targeted AR disruption in mouse osteocytes. J Bone Miner Res. 2012;27(12):2535\u201343.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"6168_CR26","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1359\/jbmr.081217","volume":"24","author":"C Chiang","year":"2009","unstructured":"Chiang C, Chiu M, Moore AJ, Anderson PH, Ghasem-Zadeh A, McManus JF, et al. Mineralization and bone resorption are regulated by the androgen receptor in male mice. J Bone Miner Res. 2009;24(4):621\u201331.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"6168_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1359\/jbmr.061117","volume":"22","author":"AJ Notini","year":"2007","unstructured":"Notini AJ, McManus JF, Moore A, Bouxsein M, Jimenez M, Chiu WS, et al. Osteoblast deletion of exon 3 of the androgen receptor gene results in trabecular bone loss in adult male mice. J Bone Miner Res. 2007;22(3):347\u201356.","journal-title":"J Bone Miner Res"},{"key":"6168_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fonc.2017.00163","volume":"7","author":"MC Farach-Carson","year":"2017","unstructured":"Farach-Carson MC, Lin SH, Nalty T, Satcher RL. Sex Differences and Bone Metastases of Breast, Lung, and Prostate Cancers: Do Bone Homing Cancers Favor Feminized Bone Marrow? Front Oncol. 2017;7:163.","journal-title":"Front Oncol"},{"issue":"12","key":"6168_CR29","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/s41416-018-0108-8","volume":"118","author":"S Neumeyer","year":"2018","unstructured":"Neumeyer S, Banbury BL, Arndt V, Berndt SI, Bezieau S, Bien SA, et al. Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer. Br J Cancer. 2018;118(12):1639\u201347.","journal-title":"Br J Cancer"},{"issue":"9","key":"6168_CR30","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.leukres.2008.12.004","volume":"33","author":"Q Li","year":"2009","unstructured":"Li Q, Yu K, Tian X, Kong F, You Y, Chen Z, et al. 17beta-Estradiol overcomes human myeloma RPMI8226 cell suppression of growth, ALP activity, and mineralization in rat osteoblasts and improves RANKL\/OPG balance in vitro. Leuk Res. 2009;33(9):1266\u201371.","journal-title":"Leuk Res"},{"issue":"6","key":"6168_CR31","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S2213-8587(13)70203-1","volume":"2","author":"LC Hofbauer","year":"2014","unstructured":"Hofbauer LC, Rachner TD, Coleman RE, Jakob F. Endocrine aspects of bone metastases. Lancet Diabetes Endocrinol. 2014;2(6):500\u201312.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"6168_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMoa041943","volume":"352","author":"VB Shahinian","year":"2005","unstructured":"Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med. 2005;352(2):154\u201364.","journal-title":"N Engl J Med"},{"issue":"8","key":"6168_CR33","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1359\/jbmr.060508","volume":"21","author":"R Eastell","year":"2006","unstructured":"Eastell R, Hannon RA, Cuzick J, Dowsett M, Clack G, Adams JE. Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, alone or in combination (ATAC) trial (18233230). J Bone Miner Res. 2006;21(8):1215\u201323.","journal-title":"J Bone Miner Res"},{"issue":"1\u20132","key":"6168_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0303-7207(01)00750-X","volume":"188","author":"MJ Fasco","year":"2002","unstructured":"Fasco MJ, Hurteau GJ, Spivack SD. Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Mol Cell Endocrinol. 2002;188(1\u20132):125\u201340.","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"6168_CR35","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1200\/JCO.2005.00.992","volume":"23","author":"T Mitsudomi","year":"2005","unstructured":"Mitsudomi T, Kosaka T, Endoh H, Horio Y, Hida T, Mori S, et al. Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence. J Clin Oncol. 2005;23(11):2513\u201320.","journal-title":"J Clin Oncol"},{"issue":"16","key":"6168_CR36","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1101\/gad.1824809","volume":"23","author":"X Lu","year":"2009","unstructured":"Lu X, Wang Q, Hu G, Van Poznak C, Fleisher M, Reiss M, et al. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev. 2009;23(16):1882\u201394.","journal-title":"Genes Dev"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6168-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6168-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6168-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T23:11:43Z","timestamp":1603494703000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6168-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6168"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6168-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2019,10,25]]},"assertion":[{"value":"26 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study used previously collected, deidentified data, which were deemed exempt from review by the Ethics Board of the Tianjin Medical University Cancer Institute and Hospital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1001"}}